My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 128

    1.

    Hormone therapy and risk for venous thromboembolism: comments and corrections.

    Peverill R.

    Ann Intern Med. 2001 Jan 2;134(1):80; author reply 81. No abstract available. PMID: 11187426 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hormone therapy and risk for venous thromboembolism: comments and correction.

    Goldstein MR.

    Ann Intern Med. 2001 Jan 2;134(1):81. No abstract available. PMID: 11187427 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Hormone therapy and risk for venous thromboembolism: comments and correction.

    Waitkevicz HJ, Axelrod D.

    Ann Intern Med. 2001 Jan 2;134(1):80-1. No abstract available. PMID: 11187425 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Venous thrombosis and conjugated equine estrogen in women without a uterus.

    Curb JD, Prentice RL, Bray PF, Langer RD, Van Horn L, Barnabei VM, Bloch MJ, Cyr MG, Gass M, Lepine L, Rodabough RJ, Sidney S, Uwaifo GI, Rosendaal FR.

    Arch Intern Med. 2006 Apr 10;166(7):772-80.PMID: 16606815 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Postmenopausal hormone replacement therapy and venous thromboembolism.

    Wu O.

    Gend Med. 2005;2 Suppl A:S18-27. Review.PMID: 16551553 [PubMed - indexed for MEDLINE]Related articles

    6.

    Women seek alternatives to hormone replacement therapy.

    [No authors listed]

    Altern Ther Health Med. 2002 Sep-Oct;8(5):27. No abstract available. PMID: 12233798 [PubMed - indexed for MEDLINE]Related articles

    7.

    Estrogen plus progestin and risk of venous thrombosis.

    Cushman M, Kuller LH, Prentice R, Rodabough RJ, Psaty BM, Stafford RS, Sidney S, Rosendaal FR; Women's Health Initiative Investigators.

    JAMA. 2004 Oct 6;292(13):1573-80.PMID: 15467059 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effect of progestogen and progestogen type on hemostasis measures in postmenopausal women: the Postmenopausal Estrogen/Progestin Intervention (PEPI) Study.

    Smith NL, Wiley JR, Legault C, Rice KM, Heckbert SR, Psaty BM, Tracy RP, Cushman M.

    Menopause. 2008 Nov-Dec;15(6):1145-50. No abstract available. PMID: 19186375 [PubMed - indexed for MEDLINE]Related articles

    9.

    Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.

    Smith NL, Heckbert SR, Lemaitre RN, Reiner AP, Lumley T, Weiss NS, Larson EB, Rosendaal FR, Psaty BM.

    JAMA. 2004 Oct 6;292(13):1581-7.PMID: 15467060 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    HRT: forever or never?

    Corson SL.

    Int J Fertil Womens Med. 2002 Jul-Aug;47(4):150-1. No abstract available. PMID: 12199410 [PubMed - indexed for MEDLINE]Related articles

    11.

    Estrogen plus progestin and risk of venous thrombosis.

    Scarabin PY, Oger E, Simon T, Plu-Bureau G.

    JAMA. 2005 Mar 16;293(11):1322; author reply 1322-3. No abstract available. PMID: 15769961 [PubMed - indexed for MEDLINE]Related articles

    12.

    Genetic influence of hormone-replacement therapy on venous thromboembolism.

    Sumino H, Ichikawa S, Kumakura H, Takayama Y, Kurabayashi M.

    Lancet. 2003 Oct 11;362(9391):1242. No abstract available. PMID: 14568759 [PubMed - indexed for MEDLINE]Related articles

    13.

    Estrogen plus progestin and risk of venous thrombosis.

    Blackwell RE.

    JAMA. 2005 Mar 16;293(11):1322; author reply 1322-3. No abstract available. PMID: 15769960 [PubMed - indexed for MEDLINE]Related articles

    14.

    Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study.

    Rexrode KM, Manson JE.

    Circulation. 2007 Feb 20;115(7):820-2. No abstract available. PMID: 17309929 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Hormonal therapy with patch or pill: how much does it matter?

    Schaudig K, Thomssen C.

    Thromb Haemost. 2007 Apr;97(4):503-4. No abstract available. PMID: 17393010 [PubMed - indexed for MEDLINE]Related articles

    16.

    Changes in coagulation factors and fibrinolytic components of postmenopausal women receiving continuous hormone replacement therapy.

    Nozaki M, Ogata R, Koera K, Hashimoto K, Nakano H.

    Climacteric. 1999 Jun;2(2):124-30.PMID: 11910665 [PubMed - indexed for MEDLINE]Related articles

    17.

    Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

    Hulley S, Furberg C, Barrett-Connor E, Cauley J, Grady D, Haskell W, Knopp R, Lowery M, Satterfield S, Schrott H, Vittinghoff E, Hunninghake D; HERS Research Group.

    JAMA. 2002 Jul 3;288(1):58-66.PMID: 12090863 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Venous thrombo-embolism and hormone replacement therapy.

    Whitehead M, Godfree V.

    Baillieres Clin Obstet Gynaecol. 1997 Sep;11(3):587-99. Review.PMID: 9488793 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study]

    Canonico M, Scarabin PY.

    Med Sci (Paris). 2008 Mar;24(3):228-31. French. No abstract available. PMID: 18334161 [PubMed - indexed for MEDLINE]Related articles

    20.

    Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial.

    Shapiro S.

    Climacteric. 2003 Dec;6(4):302-10; discussion 310-3.PMID: 15006251 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity